Impurities in Drug Vials Intended for Intravitreal Medication.

IF 0.7 Q4 OPHTHALMOLOGY Case Reports in Ophthalmological Medicine Pub Date : 2020-12-02 eCollection Date: 2020-01-01 DOI:10.1155/2020/8824585
Lisa Pohl, Lisa Strudel, Spyridon Dimopoulos, Focke Ziemssen
{"title":"Impurities in Drug Vials Intended for Intravitreal Medication.","authors":"Lisa Pohl,&nbsp;Lisa Strudel,&nbsp;Spyridon Dimopoulos,&nbsp;Focke Ziemssen","doi":"10.1155/2020/8824585","DOIUrl":null,"url":null,"abstract":"<p><p>Sterility is an important prerequisite for minimizing the risk of severe vision loss due to endophthalmitis after intravitreal injections. We describe three cases series of incidents where an unclear contamination of the drug solution or syringe caused the injection process to stop and continue with a new preparation. During a period of 12 months with 30,502 intravitreal injections at a tertiary center, wherein 7,076 were of the drug Aflibercept drawn up from a glass vial, three cases of the critical incident reporting system relating to intravitreal injections were identified: (1) After a typical contact with the filter cannula, the glass of an Aflibercept vial was no longer intact. (2) In the course of another injection, there was a clear deposition of debris on the outer edge of the syringe when removing the attached filter cannula. (3) After inserting the syringe into the rubber top of the vial, a whitish particle of unclear origin was identified within the drug solution. Later, this contamination/particle was identified as part of the greyish rubber that was punched out with the cannula, according to the analyses of the material sent in and the manufacturer's investigations. Thus, even in busy clinics, visual inspection of the injection solution and materials used for impurities, preferably before and after pulling them out of a vial, must be an essential part of the injection process. Even when using ready-to-use prefilled syringes (PFS), vigilance must be kept high, knowing the risk of potential contamination.</p>","PeriodicalId":9603,"journal":{"name":"Case Reports in Ophthalmological Medicine","volume":"2020 ","pages":"8824585"},"PeriodicalIF":0.7000,"publicationDate":"2020-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142807/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Ophthalmological Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/8824585","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Sterility is an important prerequisite for minimizing the risk of severe vision loss due to endophthalmitis after intravitreal injections. We describe three cases series of incidents where an unclear contamination of the drug solution or syringe caused the injection process to stop and continue with a new preparation. During a period of 12 months with 30,502 intravitreal injections at a tertiary center, wherein 7,076 were of the drug Aflibercept drawn up from a glass vial, three cases of the critical incident reporting system relating to intravitreal injections were identified: (1) After a typical contact with the filter cannula, the glass of an Aflibercept vial was no longer intact. (2) In the course of another injection, there was a clear deposition of debris on the outer edge of the syringe when removing the attached filter cannula. (3) After inserting the syringe into the rubber top of the vial, a whitish particle of unclear origin was identified within the drug solution. Later, this contamination/particle was identified as part of the greyish rubber that was punched out with the cannula, according to the analyses of the material sent in and the manufacturer's investigations. Thus, even in busy clinics, visual inspection of the injection solution and materials used for impurities, preferably before and after pulling them out of a vial, must be an essential part of the injection process. Even when using ready-to-use prefilled syringes (PFS), vigilance must be kept high, knowing the risk of potential contamination.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
玻璃体内给药药瓶中的杂质。
无菌性是玻璃体注射后眼内炎导致严重视力丧失风险最小化的重要前提。我们描述了三个病例系列事件,其中药物溶液或注射器的不明确污染导致注射过程停止并继续使用新的制剂。在12个月的时间里,在三级中心进行了30,502次玻璃体内注射,其中7,076次是从玻璃小瓶中抽取药物Aflibercept,确定了三例与玻璃体内注射有关的关键事件报告系统:(1)在与过滤管典型接触后,Aflibercept小瓶的玻璃不再完整。(2)在再次注射过程中,取下附着的滤管时,注射器外缘有明显的碎屑沉积。(3)将注射器插入小瓶橡胶盖后,在药液中发现一不明来源的白色颗粒。后来,根据对送来的材料的分析和制造商的调查,这种污染/颗粒被确定为与套管一起打孔的灰色橡胶的一部分。因此,即使在繁忙的诊所,对注射溶液和用于杂质的材料的目视检查,最好是在将它们从小瓶中取出之前和之后,必须是注射过程的重要组成部分。即使使用即用型预充式注射器(PFS),也必须保持高度警惕,了解潜在的污染风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
38
审稿时长
14 weeks
期刊最新文献
Semaglutide Inducing Resolution of Proliferative Diabetic Retinopathy: A Case Report. Quantification of Goldmann Visual Fields During Resolution of Traumatic Optic Neuropathy. A Case of Pediatric Myopia Complicated by Vitreous Cyst: A Unique Ophthalmic Challenge. Optic Neuropathy AFG3L2 Related in a Patient Affected by Congenital Stationary Night Blindness. Sudden Visual Loss After Vitreoretinal Surgery: A Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1